Sponsor Pipeline

Amplia Therapeutics Limited Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07026279 A Study of Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With… Pancreatic Cancer Metastatic Active, Not Recruiting
NCT05355298 ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of… Pancreatic Cancer Active, Not Recruiting
Disease Areas
Pancreatic Cancer (2)
Get alerts when Amplia Therapeutics Limited's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free